모든 기사 속보
[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.
[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.
본문 내용이 없는 속보 기사입니다
입력 : 2021-12-06 (23:35:15) | 수정 : 2024-07-05 (23:10:58)
주소 : https://news-korea.kr/388258 기사 공유
[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years. [More News]
[ NEWS ] [ SENS ] The FDA approval of Sensonics Holdings has been delayed . This is expected to interfere with profits for the time being , and the next application is scheduled for 2023 in two years .
[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.
[NEWS] [SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.
이 낚시 기사를 쓴 친구가 남긴 메시지
「[SENS] The FDA approval of Sensonics Holdings has been delayed. This is expected to interfere with profits for the time being, and the next application is scheduled for 2023 in two years.」
친구에게 마음을 담아 댓글을 남겨보세요
| 총 0개의 댓글이 있습니다 |